Dr. Mridul Agrawal
Dr. Mridul Agrawal is a physician, scientist, and healthcare entrepreneur dedicated to advancing the care for cancer patients. He is president and co-founder of iuvando Health, a Germany-based innovative digital health and precision oncology company that enables patients with cancer to find and access life-saving treatments within clinical trials. Prior to this, Dr. Agrawal was a research fellow at Dana-Farber Cancer Institute, Harvard Medical School, and the Broad Institute of MIT and Harvard with a focus on blood cancer. Dr. Agrawal studied medicine at Johns Hopkins University School of Medicine (Baltimore), University of Zürich, and Heidelberg University, where he graduated with a doctorate degree. He also obtained a master’s degree in Health Economics from Heidelberg University. Dr. Agrawal was also a former scholar of the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes). He has been honored with multiple highly prestigious national and international awards both in his role as a physician-scientist and entrepreneur.
Event: Panel: Why haven't we cured cancer? (October 28)